Global Glucagon-Like Peptide (GLP)-1 Agonists Weight Loss Drugs market size is expected to reach $32.87 by 2030 at 16.2%, rising prevalence of obesity fueling the growth of the market due to increasing demand
Read More
Global Glomerulonephritis market size is expected to reach $14.66 billion by 2030 at 4.7%, rising prevalence of kidney disorders driving the market growth
Read More
Global Gliosarcoma market size is expected to reach $1.6 billion by 2030 at 5%, rising incidence of brain tumors and the growing need for gliosarcoma treatment
Read More
Global Glioma Treatment market size is expected to reach $7.44 billion by 2030 at 6.8%, glioma treatment market driven by the surge in demand for personalized medicine
Read More
The glioblastoma multiforme treatment market is projected to reach $4.46 billion by 2030, growing at 10.2% CAGR, driven by targeted therapies, immunotherapy, and precision medicine adoption.
Read More
Global Glioblastoma Multiforme market size is expected to reach $3.94 billion by 2030 at 7.8%, impact of rising brain disorder cases on the market growth
Read More
Global Glaucoma market size is expected to reach $10.62 billion by 2030 at 5.3%, impact of rising chronic eye conditions on vision loss and treatment demand
Read More
Global Gingivitis market size is expected to reach $9.3 Billion by 2030 at 4.5%, increasing prevalence of gum disease fueling the growth of the market due to rising cases and unhealthy lifestyle factors
Read More
Global Gingival Recession market size is expected to reach $4.42 Billion by 2030 at 6%, increasing awareness of oral health fueling the growth of the market due to rising focus on prevention and treatment of dental issues
Read More
Global Giant-Cell Arteritis market size is expected to reach $1.39 billion by 2030 at 4.3%, segmented as by prednisone, oral prednisone, intravenous (iv) prednisone, low-dose prednisone therapy, high-dose prednisone therapy
Read More